Pages that link to "Q70331451"

The following pages link to Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients (Q70331451):

Displaying 39 items.

• Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma (Q24198076) (← links)
• Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma (Q24246343) (← links)
• Holding chambers versus nebulisers for beta-agonist treatment of acute asthma (Q24248679) (← links)
• Salmeterol. An appraisal of its quality-of-life benefits and potential pharmacoeconomic positioning in asthma (Q33569111) (← links)
• Hospital admission rates for asthma and respiratory disease in the West Midlands: their relationship to air pollution levels (Q33605126) (← links)
• Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group (Q33976334) (← links)
• The chronic obstructive pulmonary disease exacerbation (Q34149554) (← links)
• Status asthmaticus. From the emergency department to the intensive care unit (Q34286681) (← links)
• Discharge of the asthmatic patient (Q34286702) (← links)
• Pharmacologic treatment of the adult hospitalized asthma patient (Q34286710) (← links)
• The limited incorporation of economic analyses in clinical practice guidelines (Q34585520) (← links)
• Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society (Q34712368) (← links)
• The management of acute severe asthma. (Q34993905) (← links)
• Measuring costs and consequences in economic evaluation in asthma (Q35123330) (← links)
• Acute exacerbations of chronic obstructive pulmonary disease (Q35148133) (← links)
• The influence of inhaler selection on efficacy of asthma therapies (Q35169765) (← links)
• Two administration methods for inhaled salbutamol in intubated patients (Q35544935) (← links)
• Severe Chronic Obstructive Pulmonary Disease (Q35566006) (← links)
• Inhaler Use in Hospitalized Patients with Chronic Obstructive Pulmonary Disease or Asthma: Assessment of Wasted Doses (Q36052272) (← links)
• Inhalation devices for asthma. Choosing the right one could make all the difference (Q36652925) (← links)
• Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly : an appraisal of published evidence (Q36791064) (← links)
• Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations. (Q37261320) (← links)
• An Evaluation of Inhaled Bronchodilator Therapy in Patients Hospitalized for Non-Life-Threatening COPD Exacerbations (Q37949206) (← links)
• Cost comparison of bronchodilator delivery methods in Emergency Department treatment of asthma (Q39551826) (← links)
• Beta-Agonists in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (Q40493727) (← links)
• Chronic pulmonary disease in the trauma patient. (Q40630476) (← links)
• Indices of therapeutic outcome in pharmacoeconomic evaluation of drug therapy (Q41123721) (← links)
• Nebulisers for chronic obstructive pulmonary disease (Q41964597) (← links)
• Indigenous device for in circuit delivery of bronchodilator drugs through MDI (Q42128761) (← links)
• Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease (Q71025092) (← links)
• Efficacy of Metered-Dose Inhaler Administration of Albuterol in Intubated Infants (Q73614843) (← links)
• Costs and effectiveness of spacer versus nebulizer in young children with moderate and severe acute asthma (Q73641244) (← links)
• Impact of Clinical Pathways and Practice Guidelines on the Management of Acute Exacerbations of Bronchial Asthma (Q74082294) (← links)
• [Controversies in the use of beta-agonists in the treatment of acute asthma] (Q74674510) (← links)
• Economic evaluation of treatments for respiratory disease (Q74823143) (← links)
• [Treatment and prognosis of the severe exacerbation in the chronic obstructive pulmonary disease] (Q77475146) (← links)
• Application of a hospital audit to the use of nebulizers: the Case of the Hôtel-Dieu de France-Lebanon (Q82625638) (← links)
• Replacing nebulizers by MDI-spacers for bronchodilator and inhaled corticosteroid administration: Impact on the utilization of hospital resources (Q91912953) (← links)
• Evaluation of Bronchodilator Use During Chronic Obstructive Pulmonary Disease Exacerbation Inpatient Admissions (Q92688722) (← links)